Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study 沙格列汀在中国2型糖尿病患者中单药治疗和与二甲双胍联合治疗24周的有效性和安全性分析:来自沙格列汀上市后的SUNSHINE研究结果

详细信息    查看全文

• 作者：Weiqiong Gu ; Li. Liang ; Shengxiang Wang ; Yunzhi Wang ; Yanxiang Wu ; Jian Tian ; Gangyi Yang ; Chunli Piao ; Yuzhong Li ; Jianmei Yin ; Xiaoping Xin ; Xingrong Tan ; Guang Ning ; Weiqing Wang and for the SUNSHINE Study Group
• 刊名：Journal of Diabetes
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：8
• 期：6
• 页码：809-815
• 全文大小：422K
• ISSN：1753-0407

文摘

The aim of the present study was to explore the efficacy and safety of saxagliptin in a large Chinese population with type 2 diabetes mellitus (T2DM).